Article | December 19, 2023

How To Select The Right Biologics CDMO Partner

Source: Scorpius BioManufacturing

By Abby Sorensen, Marketing Manager, Scorpius BioManufacturing

GettyImages-547418608-lab-team-collaboration-planning

When selecting a biologics contract development and manufacturing organization (CDMO) partner, it is crucial to consider both essential and strategic characteristics. Essential attributes include manufacturing capabilities, capacity, quality management systems, scalability, effective communication, and regulatory experience. Strategic characteristics to consider include a fully integrated CDMO, facility considerations such as layout and workflow, risk mitigation through single-use bioprocessing facilities, ease of scale-up, ongoing process excellence, analytical method development and validation capabilities, scale considerations, formulation capabilities, and global regulatory expertise. By carefully evaluating these factors, companies can choose a biologics CDMO partner that aligns with their program's needs and goals.

Gain valuable insights into the factors to consider when selecting a CDMO, such as experience, regulatory compliance, capacity, track record, and cultural fit.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online